InMed Pharmaceuticals INM Q1 2026 earnings
Reported May 6, 2026 · Before market open
Revenue$1.3MMiss by $658.6M
EPS-$0.69Beat by $93.75
Revenue estimate$659.8M
EPS estimate-$94.44
Next report
Sep 23, 2026 (in 2 months)EPS estimate-$94.44
Versus estimates
Revenue
Diluted EPS
Ask the moment InMed Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did InMed Pharmaceuticals report Q1 2026 earnings?
- InMed Pharmaceuticals (INM) reported Q1 2026 earnings on May 6, 2026 before market open.
- What were InMed Pharmaceuticals's Q1 2026 revenue and EPS?
- InMed Pharmaceuticals reported revenue of $1.3M and eps of $-0.69 for Q1 2026.
- Did InMed Pharmaceuticals beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $659.8M by $658.6M. EPS beat the consensus estimate of $-94.44 by $93.75.
- How did InMed Pharmaceuticals's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 29.8% from $1.8M a year earlier and eps grew 64.4% from $-1.94.
- Where can I find InMed Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001062993-26-002371) and the 10-Q periodic report (0001213900-26-052920) directly on SEC EDGAR. The filing index links above go to sec.gov.